4//SEC Filing
Angel Matthew 4
Accession 0001140361-23-001698
CIK 0000748592other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 7:30 PM ET
Size
5.5 KB
Accession
0001140361-23-001698
Insider Transaction Report
Form 4
Angel Matthew
DirectorInterim President and CEO
Transactions
- Award
Stock Option (right to buy)
2023-01-12+132,003→ 132,003 totalExercise: $4.84Exp: 2033-01-12→ Common Stock, par value $0.005 per share (132,003 underlying)
Footnotes (1)
- [F1]The stock options vests and becomes exercisable over three years (subject to continued service), with 110,043 of the shares vesting on the grant date, and the remaining shares vesting in 36 substantially equal monthly tranches on the first day of each month thereafter.
Documents
Issuer
Eterna Therapeutics Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001931356
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 7:30 PM ET
- Size
- 5.5 KB